Emmanuel Hanon

Emmanuel Hanon is a highly experienced professional in vaccine research and development, currently serving as the RD strategy adviser at AstriVax and Chief Executive Officer at Vicebio, alongside a role as Chair of CEPI’s Scientific Advisory Committee. With significant leadership experience at GlaxoSmithKline, where Emmanuel held multiple senior vice president roles and was instrumental in vaccine discovery and development, Emmanuel's expertise spans across various aspects of vaccine development, including regulatory strategy, clinical monitoring, and product profiling. Emmanuel also founded Axis44, providing vaccine consultancy services, and is an active member of scientific advisory committees at Vaxcyte, GreenLight Biosciences, and Viome. Academic qualifications include a Doctorate in Veterinary Medicine and advanced degrees in immunology, underpinning a robust career dedicated to advancing public health through innovative vaccine solutions.